Latest

Jul 27, 2016
Stakeholders are looking to move up the Prescription Drug User Fee Act timeframe to gain Congressional action before the Obama administration steps down.
Jul 12, 2016
Pharmaceutical Executive
A look at how Europe’s new accelerated drug approval scheme can move existing review pathways to something better—and take a page from the FDA experience as well.
Jul 07, 2016
Patients are buried in content, so it is a must to grab a share of the narrow bandwidths that they possess, writes Casey McDonald
Jun 30, 2016
FDA's Brenda Stodart outlines the services of the Agency's Small Business and Industry Assistance (SBIA) Program.
Jun 21, 2016
Rapid growth in Medicare spending on prescription drugs is prompting a leading advisory group to recommend significant revisions in how the government pays for medicines under Part D and Part B
Jun 10, 2016
Sharing un-redacted inspection reports between FDA and EMA may reduce duplicate inspections of facilities.
Jun 06, 2016
There’s a stampede to relate prices to broader health benefits, but little consensus on how to do so, writes Jill Wechsler.
Jun 03, 2016
By Pharmaceutical Executive Editors
Policy makers "simply are not taking seriously the corrosive effect of corruption", study says.
May 31, 2016
For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
May 20, 2016
Pharmaceutical Executive
Pharm Exec’s 10th annual Brand of the Year has raced into the lead position in the treatment-shifting immuno-oncology space.
native1_300x100
lorem ipsum